Lakeshorebio

Acquired By Oceanpine Capital
Vaccines and immunotherapeutics for infectious diseases are developed.
Request Access

About Lakeshorebio

Lakeshorebio is a company was acquired by Oceanpine Capital in November 2025.. Lakeshorebio has raised $170 million across 5 funding rounds from investors including Orbimed, Haitong International Securities Group and Eight Roads Ventures. The company has 573 employees as of March 31, 2024. Lakeshorebio offers products and services including Rabies Vaccine and Hepatitis Vaccine.

  • Employees 573 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Lakeshore Biopharma Co., Ltd
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics → →
Key Metrics
  • Annual Revenue
    $85.67 M
    6
    as on Mar 31, 2024
  • Net Profit
    $-13.93 M
    77.2
    as on Mar 31, 2024
  • EBITDA
    $-1.8 M
    94.81
    as on Mar 31, 2024
  • Total Equity Funding
    $170 M (USD)

    in 5 rounds

  • Latest Funding Round
    $15 M (USD), Post-IPO

    Jul 08, 2025

  • Investors
    Orbimed

    & 12 more

  • Employee Count
    573

    as on Mar 31, 2024

  • Acquired by
    Oceanpine Capital

    & 1 more

    (Nov 21, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Lakeshorebio

Lakeshorebio is a publicly listed company on the NASDAQ with ticker symbol LSB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: LSB . Sector: Health technology · USA

Products & Services of Lakeshorebio

Lakeshorebio offers a comprehensive portfolio of products and services, including Rabies Vaccine and Hepatitis Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

The vaccine is produced using Vero cells for infectious disease prevention

Vaccines for hepatitis are developed using CHO cells and other methods for immune protection

Funding Insights of Lakeshorebio

Lakeshorebio has successfully raised a total of $170M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Post-IPO — $15.0M
  • First Round
  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Post-IPO - Lakeshorebio Valuation

investors
Feb, 2024 Amount Post-IPO - Lakeshorebio Valuation

investors
Mar, 2022 Amount Series B - Lakeshorebio Valuation Legend Capital
XS Xinsheng
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Investors in Lakeshorebio

Lakeshorebio has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Haitong International Securities Group and Eight Roads Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Legend Capital
Venture Capital firm focused on multiple sectors
Founded Year Domain Location
Orbimed
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
Eight Roads Ventures
Venture capital investment and global platform support for startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Amitabh Bachchan family office
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Signite Partners
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Sixteenth Street Capital
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
GGV Capital
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lakeshorebio

Investments
Company Name Description Domain Location Founded Year Amount
Bento Cloud
Bionic investment advisor platform
2016
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lakeshorebio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Lakeshorebio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lakeshorebio

Company Name Domain Founded year HQ Location Description
inDrive
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
Bolt
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
Gojek
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
Dunzo
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lakeshorebio

Frequently Asked Questions about Lakeshorebio

Is Lakeshorebio a funded company?

Lakeshorebio is a funded company, having raised a total of $170M across 5 funding rounds to date. The company's 1st funding round was a Series B of $40M, raised on Jun 01, 2012.

How many employees does Lakeshorebio have?

As of Mar 31, 2024, the latest employee count at Lakeshorebio is 573.

What is the annual revenue of Lakeshorebio?

Annual revenue of Lakeshorebio is $85.67M as on Mar 31, 2024.

What does Lakeshorebio do?

Research, development, and production of vaccines targeting infectious diseases are conducted by Lakeshorebio, a biotechnology firm. PIKA immune modulation technology is utilized in these efforts. The portfolio includes rabies and hepatitis B vaccines, manufactured via various cell lines. Operations focus on immunotherapeutics, with the company maintaining public trading status. The domain lakeshorebio.com is associated with these activities.

What products or services does Lakeshorebio offer?

Lakeshorebio offers Rabies Vaccine and Hepatitis Vaccine.

Is Lakeshorebio publicly traded?

Yes, Lakeshorebio is publicly traded on NASDAQ under the ticker symbol LSB.

Who are Lakeshorebio's investors?

Lakeshorebio has 13 investors. Key investors include Orbimed, Haitong International Securities Group, Eight Roads Ventures, Legend Capital, and XS Xinsheng.

What is Lakeshorebio's ticker symbol?

The ticker symbol of Lakeshorebio is LSB on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available